Get started
Author

Kapil Vashisht

ORCID: 0000-0003-3699-5428
Observed ORCID: 0000-0003-3699-5428
OpenAlex ID: A5012867126
Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody–Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide
2021 · Johann S. de Bono, Mark T. Fleming, et al. · Clinical Cancer Research · 59
Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody–Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer
2018 · Song Cho, Francesca Zammarchi, et al. · Molecular Cancer Therapeutics · 50
Role of genetic polymorphisms of CYP1A1, CYP3A5, CYP2C9, CYP2D6, and PON1 in the modulation of DNA damage in workers occupationally exposed to organophosphate pesticides
2011 · Satyender Singh, Vivek Kumar, et al. · Toxicology and Applied Pharmacology · 37
High glypican-3 expression characterizes a distinct subset of ovarian clear cell carcinomas in Canadian patients: an opportunity for targeted therapy
2020 · Katharina Wiedemeyer, Martin Köbel, et al. · Human Pathology · 11
Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody–Drug Conjugate Efficacy and Toxicity
2022 · Arnaud C. Tiberghien, Balakumar Vijayakrishnan, et al. · Molecular Cancer Therapeutics · 9
PDF
An extensive analysis of the biochemical dimensions of phytochemicals in the treatment or prevention of breast cancer
2025 · Monika Kumari, Kapil Vashisht, et al. · Phytochemistry Reviews · 4
CD28 expression in human CD163+ placental Hofbauer cells
2019 · Christopher Richardson, Wanda King, et al. · Placenta · 4
Abstract A004: MEDI3726 (ADCT-401), a novel antibody-drug conjugate targeting PSMA, has potent in vivo antitumor activity in prostate cancer patient-derived xenograft models
2018 · Song Cho, Francesca Zammarchi, et al. · Cancer Research · 1
Supplementary Data from Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody–Drug Conjugate Efficacy and Toxicity
2025 · Arnaud C. Tiberghien, Balakumar Vijayakrishnan, et al.
Supplementary Data from Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody–Drug Conjugate Efficacy and Toxicity
2023 · Arnaud C. Tiberghien, Balakumar Vijayakrishnan, et al.
Data from Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody–Drug Conjugate Efficacy and Toxicity
2023 · Arnaud C. Tiberghien, Balakumar Vijayakrishnan, et al.
Supplementary Data from Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody–Drug Conjugate Efficacy and Toxicity
2023 · Arnaud C. Tiberghien, Balakumar Vijayakrishnan, et al.
Data from Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody–Drug Conjugate Efficacy and Toxicity
2023 · Arnaud C. Tiberghien, Balakumar Vijayakrishnan, et al.
Works count: 13
Citation count: 175
H-index: 5
I10-index: 4
Year
Topic
Type